Skip to content
10-Q

Quarterly Report

RIGEL PHARMACEUTICALS INC RIGL

0001558370-25-010281

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 17.94M sh
Shares Diluted Q2 2025 · Jun 30, 2025 18.16M sh
Shares Diluted Q2 2025 · Jun 30, 2025 18.17M sh
Shares Diluted Q2 2025 · Jun 30, 2024 17.55M sh
Shares Diluted Q2 2025 · Jun 30, 2024 17.53M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 $29.64M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$4.71M
Long Term Debt Q2 2025 · Jun 30, 2025 $60M
Short Term Investments Q2 2025 · Jun 30, 2025 $54.97M
Short Term Investments Q2 2025 · Dec 31, 2024 $20.58M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $53.41M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $56.75M
Stockholders Equity Q2 2025 · Jun 30, 2025 $81.93M
Stockholders Equity Q2 2025 · Mar 31, 2025 $18.57M
Stockholders Equity Q2 2025 · Dec 31, 2024 $3.29M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$29.91M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$31.67M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$28.64M
Current Liabilities Q2 2025 · Jun 30, 2025 $86.64M
Current Liabilities Q2 2025 · Dec 31, 2024 $63.3M
Total Liabilities Q2 2025 · Jun 30, 2025 $124.8M
Total Liabilities Q2 2025 · Dec 31, 2024 $160.69M
Current Assets Q2 2025 · Jun 30, 2025 $175.39M
Current Assets Q2 2025 · Dec 31, 2024 $135.1M
Total Assets Q2 2025 · Jun 30, 2025 $206.74M
Total Assets Q2 2025 · Dec 31, 2024 $163.98M
Eps Diluted Q2 2025 · Jun 30, 2025 $3.28
Eps Diluted Q2 2025 · Jun 30, 2025 $3.91
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.06
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.53
Eps Basic Q2 2025 · Jun 30, 2025 $3.33
Eps Basic Q2 2025 · Jun 30, 2025 $3.98
Eps Basic Q2 2025 · Jun 30, 2024 −$0.06
Eps Basic Q2 2025 · Jun 30, 2024 −$0.53
Sga Expense Q2 2025 · Jun 30, 2025 $29.26M
Sga Expense Q2 2025 · Jun 30, 2025 $56.97M
Sga Expense Q2 2025 · Jun 30, 2024 $28.05M
Sga Expense Q2 2025 · Jun 30, 2024 $56.5M
Net Income Q2 2025 · Jun 30, 2025 $59.61M
Net Income Q2 2025 · Jun 30, 2025 $71.06M
Net Income Q2 2025 · Jun 30, 2024 −$1.03M
Net Income Q2 2025 · Jun 30, 2024 −$9.28M
Operating Income Q2 2025 · Jun 30, 2025 $61.1M
Operating Income Q2 2025 · Jun 30, 2025 $73.88M
Operating Income Q2 2025 · Jun 30, 2024 $447K
Operating Income Q2 2025 · Jun 30, 2024 −$6.52M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $4.5M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $8.91M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $2.81M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $4.83M
Revenue Q2 2025 · Jun 30, 2025 $101.69M
Revenue Q2 2025 · Jun 30, 2025 $155.02M
Revenue Q2 2025 · Jun 30, 2024 $36.84M
Revenue Q2 2025 · Jun 30, 2024 $66.38M